Companies: 10,795·Total market cap: $144.5T
Trinity Biotech plc

Trinity Biotech plc

TRIBNASDAQHealthcare● Active
$0.68
+$0.01(+1.87%)
Market Cap$7063227
P/E Ratio—
52W High$3.44
52W Low$0.5
Overview
Stock ranking:Medical - Diagnostics & Research·Healthcare·View All Market Cap Rankings →

Trinity Biotech plc (TRIB) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · TRIB · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-2.01trib eps ttm · trib earnings per shareEarnings history
PE Ratio (TTM)—trib pe ratio ttm · trib price to earningsPE Ratio deep dive
Revenue (TTM)$43.9Mtrib revenue ttm · trib annual revenueFull revenue history
Dividend Yield0.25%does trib pay dividends · trib dividend yieldDividend history
Shares Outstanding18.6Mtrib shares outstanding · trib floatShares outstanding history
Next EarningsSep 3, 2026Est.trib earnings date · trib next earningsEarnings history

Explore Trinity Biotech plc Data

trib stock data · financials
Market Cap$7.1Mtrib market cap · trib valuation
Analyst Forecast$— · Buy
Dividends0.25%does trinity biotech plc pay dividends · trib dividend yield
Revenue$43.9M-28.65%trinity biotech plc annual revenue · trib revenue
EarningsEPS $-2.00-12.99%trib earnings · trib eps
PE Ratio—trib pe ratio · trib price to earnings

Financial Snapshot

Full Financials
FY 2025Revenue$43.9M▼ 28.65% YoY
202320242025
trinity biotech plc revenue · trib revenue 2025
FY 2025Net Income-$37.5M▼ 17.94% YoY
202320242025
trinity biotech plc net income · trib profit 2025
FY 2025EPS$-2.00▼ 12.99% YoY
202320242025
trib eps · trinity biotech plc earnings per share 2025
TTM:Revenue: $43.9MNet Income: -$37.4MEPS: $-2.01View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy4 analystsis trib a buy · trib analyst rating
Strong Buy
0
Buy
3
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$—Low
$0.68Current
$—Avg Target
$—High
trib price target · trib 12 month forecast

Total: 4 · Buy rate: 75.0%

Stock Performance

Full History
1D+1.87%
1W-9.21%
1M+12.04%
3M-6.70%
YTD-14.03%
1Y+3.98%
5Y-95.78%

About Trinity Biotech plc

CEOJohn Gillard
IPO DateOct 21, 1992
Employees380
CountryIE
Websitetrinitybiotech.com

Trinity Biotech plc an Irish enterprise founded in 1992 and headquartered in Bray, is engaged in the acquisition, development, manufacturing, and global distribution of medical diagnostic solutions. …

Medical - Diagnostics & ResearchHealthcareNASDAQADRIE

what is trinity biotech plc · trib stock overview · trinity biotech plc company profile · who is trinity biotech plc ceo · trib NASDAQ · trinity biotech plc headquarters · trinity biotech plc business segments

About Stock Overview & Key Data

Trinity Biotech plc (TRIB) is a Healthcare company in the Medical - Diagnostics & Research industry, listed on NASDAQ since Oct 21, 1992. As of the latest trading session, TRIB stock price is $0.68, with a market capitalization of $7.1M. The stock has returned +3.98% over the past 12 months and -14.03% year-to-date.

According to 4 Wall Street analysts, the consensus rating for Trinity Biotech plc stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Trinity Biotech plc reported revenue of $43.9M and net income of -$37.5M. For detailed data — including Trinity Biotech plc revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Trinity Biotech plc (TRIB) stock price is $0.68. The stock is traded on NASDAQ under the ticker symbol TRIB. The 52-week range is $0.50 – $3.44.

TRIB stock priceTRIB quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice